Waters Corporation management check

WAT · Health Care · Life Sciences Tools & Services · CEO Dr. Batra

Filings as of

76
Management score, ranked 101st of 487 · 9th of 60 in Health Care4 good · 2 to watch · 0 flaggedStrongest: owner returns · Weakest: CEO cost · Best and worst run in Health Care →

The seven checks

  • Good

    Have owners done well?

    Beat its chosen peersOwners$154Peers$69

    What $100 became since fiscal 2021

    100100th
    Detail

    $100 invested at the start of fiscal 2021 grew to $154, against $69 for the peer group the company picked itself.

  • Good

    Does pay follow performance?

    Pay rose and fell with returns20212025

    Pay actually paid $100 value, each on its own scale

    8964th
    Detail

    Over 5 years, the CEO's pay actually paid (equity valued at the share price) had a correlation of 0.77 with shareholder return. 1 means pay moved in step; below 0, the opposite way.

  • Watch

    What does the CEO cost owners?

    2.2% of net income

    $14.0m pay · $642.6m net income, FY2025

    0.1%1%3%10%
    2227th
    Detail

    $14.0m of reported pay in fiscal 2025, against $642.6m of net income.

  • n/a

    Do they own the stock?

    No recent CEO filing
    ——

    Light activity: no buys, $1.4m sold in six months.

  • Watch

    Are owners being diluted?

    Share count growing2021 · 62m2025 · 60m

    Diluted shares +0.4% a year; flagged above +2%

    0%10%20%

    Stock pay 1.7% of revenue

    4527th
    Detail

    Diluted shares changed +0.4% a year over the last three fiscal years. Stock-based pay was 1.7% of revenue in the latest year.

  • Good

    Is leadership stable?

    4 leadership filings in 3 years

    4 filings under 8-K 5.02 in 3 years

    0101420+

    CEO: Dr. Batra

    100100th
    Detail

    CEO in the pay table: Dr. Batra. 4 filings under 8-K item 5.02 (officers or directors leaving or joining, or new pay arrangements) in the last 3 years.

  • Good

    Are the books clean?

    No red flags on file

    Since 2021

    • 0Restated
    • 0Auditor changes
    • 0Late filings
    • 010-K amended
    100100th
    Detail

    No restatements, auditor changes or late filings since 2021.

  • Reading the scores

    Each check scored 0–100 from its own figure. The tick is the Health Care median; the ordinal is the share of ranked S&P 500 companies it matches or beats.

    Hover a chart for its figures. Detail has the full reading.

Pay versus performance

From the proxy statement filed April 9, 2026.

CEO pay as reportedActually paid ⓘWhat $100 becamePeer group the company chose
−$1.1m$9.0m$19.1m$10020212022202320242025$154$69

Pay tied most to adjusted non-GAAP organic net income growth

Other key measuresAdjusted non-GAAP organic constant currency revenue growthAdjusted non-GAAP organic net income growthRelative total shareholder return

Show the figures
Fiscal yearCEOCEO payActually paidOther executives (avg)$100 becamePeersNet income
2025Dr. Batra$14.0m$10.6m$3.2m$154$69$642.6m
2024—$11.1m$14.6m$2.5m$150$72$637.8m
2023—$8.7m−$1.1m$2.3m$133$76$642.2m
2022—$9.4m$10.8m$2.7m$138$86$707.8m
2021—$8.7m$19.1m$2.4m$151$127$692.8m

Insiders and the CEO's stakeQuiet

Light activity: no buys, $1.4m sold in six months.

Open-market trades by officers and directors since May 21, 2026.

  • SoldChristopher A KueblerDirector$1.4mAug 6, 2026

Leadership and governance on file

20222023202420252026Leadership 10Votes 6
All 10 filings

Latest shareholder vote results: May 22, 2026, including the say-on-pay vote.

Where the money went

2021–2025: $1.4bn returned to owners in buybacks and dividends, 41% of net income, and $208.2m of pay in stock.

Net incomeBuybacksDividendsStock-based payDiluted shares
$0$353.9m$707.8m20212022202320242025Shares62m60m59m60m60m
Show the figures
Fiscal year20212022202320242025
Revenue$2.8bn$3.0bn$3.0bn$3.0bn$3.2bn
Net income$692.8m$707.8m$642.2m$637.8m$642.6m
Stock-based pay$29.9m$42.6m$36.9m$44.7m$54.1m
Buybacks$648.9m$626.1m$70.3m$13.5m$14.7m
Dividends—————
Diluted shares62m60m59m60m60m

Educational only, not investment advice. Figures are as filed with the SEC: pay from the proxy's pay-versus-performance table, capital allocation from 10-K XBRL data, insider trades from Form 4s over the last six months, events from the last 5 years of filings. The peer group is the one the company chose. See the method.